Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor are extending and improving the lives of patients with liver cancer.
![Graphic shows microscopic Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor in a liver.](https://nextgenmurr.missouri.edu/wp-content/uploads/2024/04/032624ABK-1024x576.jpg)
March 28, 2024
Liver cancer is one of the deadliest forms of the disease, and the American Cancer Society estimates a 71 percent mortality rate for patients in the U.S. diagnosed with primary liver and intrahepatic bile duct cancer.